沃森生物(300142.SZ)：公司四价流脑结合疫苗目前处于III期临床研究阶段

Group 1 - The core point of the article is that Watson Bio (300142.SZ) is currently in the III phase of clinical research for its quadrivalent meningococcal vaccine and will strictly adhere to national drug registration procedures and relevant regulations [1]